Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Spilanthol is a bioactive fatty acid amide (alkylamide) primarily derived from the plant *Acmella oleracea*, commonly known as the toothache plant. It is recognized for its diverse pharmacological properties, including analgesic, anti-inflammatory, and local anesthetic effects. Recent clinical research, such as that presented at the MDA Clinical & Scientific Conference 2026, has explored its potential as a dietary supplement to enhance neuromuscular performance. In a randomized controlled trial involving middle-aged men, daily supplementation with 17.5 mg of spilanthol, when combined with resistance exercise and balance training, significantly improved peak countermovement power and functional strength (as measured by the sit-to-stand test). The compound is thought to modulate neuromuscular function and potentially augment muscle strength and size, making it a candidate for addressing age-related declines in muscle performance and coordination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on spilanthol.